TLRYBought (100) TLRY at $8.22 then did a Sell Call with a strike price of $9.50. If It gets executed that will be 10% made off the 100 shares + $43 premium WIN WIN. TLRY does look like the bottom is in Could ride it to $52 if lucky!
TLRY
Tilray HUGE VolumeTilray - Short Term - We look to Buy at 7.44 (stop at 6.71)
We look to buy dips. Trading volume is increasing. Previous resistance at 7.20 now becomes support. Last week Marabuzo is located at 8.56. Traded to the highest level in 70 weeks.
Our profit targets will be 9.82 and 10.30
Resistance: 10.00 / 13.50 / 22.00
Support: 7.20 / 5.00 / 2.50
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
Tilray (Cannabis)Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. Earnings Coming soon
$TLRY U.S. Cannabis LegalizationThis breakout may have some merit to it. Two overhead resistances broke with the second-highest weekly and highest daily volume on record.
Tilray TLRY Highest Daily Volume EVER! 220 MILLION Shares TradedWhoahhh the TLRY volume!! Highest ever on the daily: 220M shares traded so far...
This is wild folks... this is what we need to be confident in the bottom being set. massive volume... 172 BILLION dollars traded in Tilray alone and we still have 1.25 hours to go. Remember volume usually precedes price:
Tilray (NASDAQ: $TLRY): Federal MJ Legalization Vote #2! 🌿Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. It offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. The company operates Tilray Medical, a medical platform that provides GMP-certified flowers, oils, vapes, edibles, and topicals. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Tilray, Inc. Tilray Brands Inc. was incorporated in 2018 and is headquartered in New York, New York.
Tilray ROCKET! 60x the moneyTilray leading cannabis provider in Europe.
Multiple european countries have legalised in 2020, 2021 and more coming in 2022.
Tilray is one of the very few GMP Certified companies.
And they also hold a big stake in the US Market which sooner or later will legalize.
Tilray is the Tesla of weed stocks.
I expect the stock to hit a new ATH between 2022-2025.
Dont miss this opportunity of a life time.
SNDL - Day of reckoning coming for weed stonks? Weed stocks are having a great week so far and I don't think the fomo has kicked in yet.
SNDL is breaking out on weekly into the new channel and can squeeze higher above a dollar. I think this will continue running into month/quarter end and potentially 5-7+ dollars into Q2.
This entire sector has been beaten down for years as money has shifted into tech and growth. As the Fed tightens, people will look to value vs growth and this sector is at/near all time lows. Risk to reward is a no brainer.
Tilray Brands (USA: $TLRY) Investors About To Get Lucky 🍀Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. It offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. The company operates Tilray Medical, a medical platform that provides GMP-certified flowers, oils, vapes, edibles, and topicals. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Tilray, Inc. Tilray Brands Inc. was incorporated in 2018 and is headquartered in New York, New York.
Descending Channel for TLRY?It appears though Tilray, TLRY on NASDAQ is trading in a descending channel.
A bounce to the downward sloping resistance of the pattern is expected near term, the company is a pump machine with the PRs, Irwin has his eyes on more than Hexo, so in my opinion, the company will continue M&A, and has the rights to change the terms of agreement with Hexo pending due diligence.
Watch out for the DMI, currently trading neutral, if the blue line breaks above the orange a breakout to the upside is either near term or occurring in real-time, and on the contrary, if the blue line on the DMI crosses the red to the downside hold your ankles.
If history is to repeat itself, the RSI has called the micro top of each bounce to the upside inside the descending channel.
A descending channel is drawn by connecting the lower highs and lower lows of a security's price with parallel trendlines to show a downward trend. Officially, the space between the trendlines is the descending channel, which falls under the broad category of trend channels.
A descending channel is drawn by connecting the lower highs and lower lows of a security's price with parallel trendlines to show a downward trend.
Traders who believe a security is likely to remain within its descending channel can initiate trades when the price fluctuates within its channel trendline boundaries.
A more potent signal occurs with a breakout, which is when a security's price breaches an established channel's boundaries, either on the upper or lower side.
Trading range for the foreseeable future between 9 Dollars & 3 Dollars. The volatility of the market is likely to cause fake-outs in both directions, trade accordingly.
$TLRY blue dream sniper 👁🗨*This is not financial advice, so trade at your own risks*
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management*
Today team purchased shares of marijuana company Tilray Brands $TLRY at $6.10 per share. Our take profit is $7 with a stop loss at $5.90.
Our Entry: $6.10
Take Profit: $7
Stop Loss: $5.90
If you want to see more, please like and follow us @SimplyShowMeTheMoney
Weed stocksTLRY, CGC, SNDL, ACB
So far this year looks like the weed stocks have found a temporary bottom. Most are curling off the bottom. TLRY has lots of resistance above but last few days has been pushing with increasing volume. Just keep an eye on them if they really start squeezing. Most likely will be looking at some calls this week to see if we can get some follow through. Of course it has been in a nice downtrend overall for over a year but I do like what I have seen last few days.
Tiray long at $9 ?I have been studying TLRY for a long time.. this trade feels just about right with excellent entry
Can it go lower ? yes! but downside is minimal then upside potential.. since this is a long term trade for me, and I would be adding even if it dips or even consolidates here..
this is looking like accumulation to me here
SL is based on your position and risk tolerance
there are few exits
TP1 - $18.25
TP2 - $38
TP3 - $70
I have a large position (compared to my other trades) as I feel comfortable with fundamentals and entry price. I would personally not take any profits until TP2 or TP3 and wait a little longer
will update this idea as it develops.
lets do this!
$TLRY smoking on that tilray pack 👁🗨*This is not financial advice, so trade at your own risks*
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management
Recap: The market has been in loading zone the past couple of weeks. My team is loading up shares of companies that we believe are likely to benefit from this rally.
Today before the market closed my team purchased shares of marijuana company Tilray Brands $TLRY at $6.26 per share. Our take profit is $10
ENTRY: $6.26
TAKE PROFIT: $10
(OPTIONAL) STOP LOSS: $5.50
If you want to see more, please like and follow us @SimplyShowMeTheMoney
Are pot stocks actually making money?One of the "themes" I have been watching for 2022 is the possible resurgence of pot stocks. Every year has its theme and "anything can happen."
Over the weekend I watched a short Vice documentary following the current state of legal (and illegal) weed in California. You can watch here:
www.youtube.com
We can chalk this up to "unintended consequences" where the new decriminalized regime lowers penalties for growing black market marijuana while the oppressive tax structure is prohibitive to legal marijuana business. I cannot say if this is a "because California" problem or if this the model that will play out state-by-state. Pot stocks, led by Tilray NASDAQ:TLRY , had a rally in 2021 following the election of Biden and Democratic Congress in the USA. Investors assumed this was bullish for the regulated weed industry but examples of what is playing out in California right now show the potential extraneous factors to running a legal marijuana business in the United States. The wheels of politics turn slowly and it could be a very long time before politicians and business owners get it right.
If we look at the largest company by revenue in the United States, Green Thumb Industries OTC:GTBIF , for the last 5 earnings they have made money but the Weekly chart is dangerously close to a full bearish trend. I'll continue watching these stocks and this sector but I'm not a buyer yet.
Tilray (NASDAQ: $TLRY) Topping Headlines Today Across All Media!Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Cannabis Sector To Run 2022 6-7x Potential Canopy GrowthHey the cannabis sector has underperformed the stock market indexes in 2021, this will run in 2022, stay updated in January for monthly momentum inflections. CGC has a 6-7x potential from here. This should be the first big sector swing followed by airlines and renewable energy in 2022.
TLRYReversal patterns printing on daily, oversold stoch on weekly and selling momentum is slowing down. We might be bottomed out and this on has a good R:R.
The support area should be help no matter what or this trade is a stop :) will try to update this in time..
Peace
TLRY is buying up real assets, 1. Whisky Distillery 2. Brewery(Opinion Only)
But this looks like it could be the next $AMC or $GME with the fundamentals beginning too shape up here.
Disclosure: I have purchased 100 shares afterhours because I loved the business plan from CEO on CNBC.
Goodluck
$TLRY sniper edition #6*This is not financial advice, so trade at your own risks*
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management*
Recap: On October 21, 2021 My team entered $TLRY at $11.56 per share. We increased our position on October 29, 2021 at $10.30 per share.
My team averaged down on our position today at $9.50 per share bringing our share average down to $10.45. We have also updated our take profits.
OUR FIRST ENTRY: $11.56
OUR 2ND ENTRY: $10.30
OUR 3RD ENTRY: $9.50
TAKE PROFIT 1: $15.30
TAKE PROFIT 2: $29.0
If you want to see more, please like and follow us @SimplyShowMeTheMoney
